Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Other Non Operating Income (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Other Non Operating Income for 12 consecutive years, with -$18000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income rose 60.0% year-over-year to -$18000.0, compared with a TTM value of -$141000.0 through Sep 2025, up 45.14%, and an annual FY2024 reading of -$257000.0, down 38.17% over the prior year.
  • Other Non Operating Income was -$18000.0 for Q3 2025 at Lisata Therapeutics, down from -$7000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at -$7000.0 in Q2 2025 and bottomed at -$187000.0 in Q1 2024.
  • Average Other Non Operating Income over 3 years is -$52000.0, with a median of -$14000.0 recorded in 2024.
  • Peak annual rise in Other Non Operating Income hit 90.67% in 2024, while the deepest fall reached 1338.46% in 2024.
  • Year by year, Other Non Operating Income stood at -$11000.0 in 2023, then changed by 0.0% to -$11000.0 in 2024, then crashed by 63.64% to -$18000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for LSTA at -$18000.0 in Q3 2025, -$7000.0 in Q2 2025, and -$105000.0 in Q1 2025.